Skip to main navigation
  • About
    • Our Mission
    • Core Values
    • Leadership
    • Partners
  • CRISPR/Cas9
    • What’s CRISPR/Cas9?
    • How CRISPR/Cas9 Works
    • Types of Edits
    • Glossary
  • Programs & Pipelines
    • Full-Spectrum Approach
    • Our Pipeline
    • In Vivo Therapies
    • Ex Vivo Therapies
  • Patients & Families
    • Our Commitment
    • Clinical Trials
    • Community Perspectives & Resources
    • Expanded Access Policy
  • Healthcare Professionals
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Deck
    • Events & Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
  • Full-Spectrum Blog
  • Contact
logo
  • Full-Spectrum Blog
  • Contact
  • About
    • Our Mission
    • Core Values
    • Leadership
    • Partners
  • CRISPR/Cas9
    • What’s CRISPR/Cas9?
    • How CRISPR/Cas9 Works
    • Types of Edits
    • Glossary
  • Programs & Pipelines
    • Full-Spectrum Approach
    • Pipeline
    • In Vivo Therapies
    • Ex Vivo Therapies
  • Patients & Families
    • Our Commitment
    • Clinical Trials
    • Community Perspectives & Resources
    • Expanded Access Policy
  • Healthcare Professionals
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Deck
    • Events & Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
Investors & Media

Events & Presentations

Investor Relations

  • Overview
  • Press Releases
  • Scientific Publications & Presentations
  • Corporate Deck
  • Events & Presentations
  • Press Kit
  • Corporate Governance
  • Financial Info
  • Stock Info
  • Analyst Coverage
  • Investor Resources

Events and Presentations

  • Upcoming Events
  • Past Events
  • Presentations
  • ESG Report
All Past Events
2022
2021
2020
Jun 24, 2022 8:00 AM EDT
Intellia Therapeutics Call to Discuss Interim Clinical Data from NTLA-2001 Phase 1 Study
Click Here for Webcast

Supporting Materials

NTLA-2001 for ATTR Amyloidosis: Interim Clinical Results from Ongoing Phase 1 Trial 1 MB
Jun 14, 2022 9:00 AM EDT
Intellia Therapeutics 2022 Annual Meeting of Shareholders

Location:

Virtual meeting via internet
Jun 9, 2022 8:30 AM EDT
Jefferies Healthcare Conference

Location:

New York, New York
Click Here for Webcast
May 5, 2022 8:00 AM EDT
Intellia Therapeutics First Quarter 2022 Earnings Conference Call

US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast
Mar 15, 2022 9:00 AM EDT
Barclays Global Healthcare Conference
Miami, Florida
Click Here for Webcast
Feb 28, 2022 4:30 PM EST
Intellia Therapeutics Call to Discuss Interim Clinical Data from NTLA-2001 Phase 1 Study
Click here for webcast

Supporting Materials

NTLA-2001 for ATTR Amyloidosis: Interim Clinical Results from Ongoing Phase 1 Trial 1 MB
Feb 24, 2022 8:00 AM EST
Intellia Therapeutics Fourth Quarter and Full-Year 2021 Earnings Conference Call

US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click here for a simultaneous live webcast of the call and replay
Jan 12, 2022 2:15 PM EST
40th Annual J.P. Morgan Healthcare Conference

Virtual

Click Here for Webcast

Supporting Materials

J.P. Morgan Healthcare Conference Presentation 1.3 MB
Dec 1, 2021 8:50 AM EST
Evercore ISI 4th Annual HealthCONx Conference
Virtual
Click Here for Webcast
Nov 15, 2021 9:00 AM EST
Barclays Gene Editing & Gene Therapy Summit
Virtual
Click Here for Webcast
Nov 4, 2021 8:00 AM EDT
Intellia Therapeutics Third Quarter 2021 Earnings Conference Call

US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click here for a simultaneous live webcast of the call and replay.
Oct 4, 2021 10:30 AM EDT
Chardan’s 5th Annual Genetic Medicines Conference
Click Here for Webcast
Sep 13, 2021 7:00 AM EDT
H.C. Wainwright 23rd Annual Global Investment Conference

Virtual

Click Here for Webcast
Sep 9, 2021 10:40 AM EDT
Wells Fargo Securities Healthcare Conference

Virtual

Click Here for Webcast
Aug 5, 2021 8:00 AM EDT
Intellia Therapeutics Second Quarter 2021 Earnings Conference Call

US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast Replay
Jun 28, 2021 8:00 AM EDT
Intellia Therapeutics Call to Discuss Interim Clinical Data from NTLA-2001 Phase 1 Study
Click Here for Webcast
Jun 23, 2021 9:00 AM EDT
Intellia Therapeutics 2021 Annual Meeting of Shareholders

Location:

Virtual meeting via internet
Jun 22, 2021 8:00 AM EDT
Intellia Therapeutics Corporate Update Call to Discuss Launch of New Universal CAR-T Company with Cellex and Blackstone Life Sciences
Click Here for Webcast
Jun 2, 2021 2:00 PM EDT
Intellia Therapeutics at the Jefferies Healthcare Conference

Location:

Virtual
Click Here for Webcast
May 6, 2021 8:00 AM EDT
Intellia Therapeutics First Quarter 2021 Earnings Conference Call

US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast Replay
Mar 16, 2021
Intellia Therapeutics, Inc. at the Oppenheimer Annual Healthcare Conference

Location: Virtual

Mar 10, 2021 9:45 AM EST
Intellia Therapeutics, Inc. at the Barclays Global Healthcare Conference

Location: Virtual

Click Here for Webcast
Feb 25, 2021 8:00 AM EST
Intellia Therapeutics Fourth Quarter and Full-Year 2020 Earnings Conference Call

US dial-in: 1-833-316-0545
International dial-in: 1-412-317-5726
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast Replay
Nov 16, 2020 9:45 AM EST
Intellia Therapeutics, Inc. at the Barclays Gene Editing & Gene Therapy Summit
Click Here for Webcast
Nov 11, 2020 2:45 PM EST
Intellia Therapeutics, Inc. at the Credit Suisse 29th Annual Virtual Healthcare Conference
Click Here for Webcast
Nov 5, 2020 8:00 AM EST
Intellia Therapeutics Third Quarter 2020 Earnings Conference Call

US dial-in: 1-877-317-6789
International dial-in: 1-412-317-6789
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast Replay
Oct 5, 2020 9:00 AM EDT
Intellia Therapeutics, Inc. at Chardan’s Virtual 4th Annual Genetic Medicines Conference
Click Here for Webcast
Sep 9, 2020 10:50 AM EDT
Intellia Therapeutics, Inc. at the Baird’s 2020 Virtual Global Healthcare Conference
Click Here for Webcast
Aug 11, 2020 3:30 PM EDT
Intellia Therapeutics, Inc. at the Wedbush PacGrow Healthcare Conference
Click Here for Webcast
Aug 6, 2020 8:00 AM EDT
Intellia Therapeutics Second Quarter 2020 Earnings Conference Call

US dial-in: 1-877-317-6789
International dial-in: 1-412-317-6789
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast Replay
Contact IR Contact IR
Email Alerts
RSS Feeds
RSS Feeds
Print Page

Footer Links

  • Cookie Policy
  • Terms of Use
  • Privacy Policy

© Intellia Therapeutics, Inc. 2022

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.